Pharsight

Drugs that contain Ciprofloxacin

1. Cipro patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US6136347 BAYER HLTHCARE Flavor-masked pharmaceutical compositions
Jan, 2013

(11 years ago)

US6136347

(Pediatric)

BAYER HLTHCARE Flavor-masked pharmaceutical compositions
Jul, 2013

(10 years ago)

US5695784 BAYER HLTHCARE Flavor-masked pharmaceutical compositions
Dec, 2014

(9 years ago)

US5695784

(Pediatric)

BAYER HLTHCARE Flavor-masked pharmaceutical compositions
Jun, 2015

(8 years ago)

Market Authorisation Date: 26 September, 1997

Treatment: Use of approved formulations to treat all approved disease indications

Dosage: FOR SUSPENSION;ORAL

How can I launch a generic of CIPRO before it's drug patent expiration?
More Information on Dosage

CIPRO family patents

Family Patents

2. Otiprio patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance.
US9603796 ALK ABELLO Controlled release antimicrobial compositions and methods for the treatment of otic disorders
Apr, 2029

(4 years from now)

These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9205048 ALK ABELLO Controlled release antimicrobial compositions and methods for the treatment of otic disorders
Apr, 2029

(4 years from now)

US11369566 ALK ABELLO Controlled release antimicrobial compositions and methods for the treatment of otic disorders
Apr, 2029

(4 years from now)

US9233068 ALK ABELLO Controlled release antimicrobial compositions and methods for the treatment of OTIC disorders
Dec, 2029

(5 years from now)

US8318817 ALK ABELLO Controlled release antimicrobial compositions and methods for the treatment of otic disorders
Apr, 2030

(5 years from now)

US9220796 ALK ABELLO Sterilization of ciprofloxacin composition
Jul, 2035

(11 years from now)

US11040004 ALK ABELLO Otic gel formulations for treating otitis externa
Nov, 2037

(13 years from now)

US11246863 ALK ABELLO Ciprofloxacin otic composition and kits and method for using same
Nov, 2038

(14 years from now)

Drug Exclusivity Drug Exclusivity Expiration
New Product(NP) Dec 10, 2018
New Indication(I-770) Mar 02, 2021

Market Authorisation Date: 10 December, 2015

Treatment: Treatment of pediatric patients with otitis media with effusion undergoing tympanostomy tube placement; Treatment of otic infection or inflammation; The treatment of acute otitis externa in patients 6...

Dosage: INJECTABLE, SUSPENSION;OTIC

More Information on Dosage

OTIPRIO family patents

Family Patents